TITLE

Bevacizumab

PUB. DATE
September 2010
SOURCE
Reactions Weekly;9/18/2010, Issue 1319, p11
SOURCE TYPE
Periodical
DOC. TYPE
Case Study
ABSTRACT
The article describes the case of a male neonate who developed choroidal rupture after he received combined laser ablation treatment and intravitreal bevacizumab for aggressive posterior retinopathy of prematurity (ROP).
ACCESSION #
53851288

 

Related Articles

  • Avastin May Offer ROP Treatment.  // Review of Ophthalmology;Mar2011, Vol. 18 Issue 3, p10 

    The article reviews the article "Avastin May Offer ROP Treatment" which appeared in the "New England Journal of Medicine" in February 17, 2011.

  • Bevacizumab.  // Reactions Weekly;9/22/2012, Issue 1420, p13 

    The article describes the cases of three male infants who received bevacizumab for stage 3 retinopathy of prematurity but they developed atypical fibrous traction band formation and tractional retinal detachment during treatment.

  • Respuestas tisulares y vasculares en retinopatía hipertensiva con anticuerpos monoclonales como terapia antiangiogénica. GARZÓN PARRA, SANDRA JOHANNA; BONILLA HERNÁNDEZ, ADRIANA MARÍA; PULIDO LADINO, ANDRÉS FELIPE; LAFOSSE, EDOUARD // Ciencia y Tecnología para la Salud Visual y Ocular;jul-dic2013, Vol. 11 Issue 2, p79 

    Objective: to identify the ophthalmic use of monoclonal antibodies in hypertensive retinopathy and their effect on visual acuity (VA), vascular angiogenesis and changes in the ocular fundus of hypertensive patients. Materials and methods: Literature was reviewed in the Pubmed, Medline, Embasi,...

  • Retinal Detachment Despite Aggressive Management of Aggressive Posterior Retinopathy of Prematurity. Suk, Kevin K.; Berrocal, Audina M.; Murray, Timothy G.; Rich, Ryan; Major, James C.; Hess, Ditte; Johnson, Rose A. // Journal of Pediatric Ophthalmology & Strabismus;Nov/Dec2010, Vol. 47 Issue 6, pe1 

    Posterior retinopathy of prematurity (ROP) is unusual in its atypical features and its aggressive, rapidly progressive course. It is more difficult to recognize and to treat, with many of these eyes progressing to retinal detachment despite multiple treatments with laser or cryotherapy. The...

  • Intravitreal bevacizumab for stage 3+ retinopathy of prematurity.  // Africa Health;May2011, Vol. 33 Issue 4, p65 

    The article reports on the randomized clinical trial which compares the therapeutic effectiveness of using intravitreal bevacizumab for stage 3+ retinopathy of prematurity against the conventional laser therapy.

  • Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity. EROL, MUHAMMET KAZIM; COBAN, DENIZ TURGUT; SARI, ESIN SOGUTLU; BILGIN, AHMET BURAK; DOGAN, BERNA; OZDEMIR, OZDEMIR; TUNAY, ZUHAL OZEN // Arquivos Brasileiros de Oftalmologia;Nov/Dec2015, Vol. 78 Issue 6, p340 

    Purpose: To compare the efficacy of intravitreal ranibizumab and bevacizumab treatment for type 1 retinopathy of prematurity (ROP). Methods: 36 eyes of 20 patients with type 1 ROP who received anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections between August 2011 and...

  • An interventional comparative.  // Review of Ophthalmology;Aug2013, Vol. 20 Issue 8, p74 

    The article focuses on a comparative study of refractive error in infants who underwent a single intravitreal bevacizumab injection for treatment of threshold retinopathy of prematurity, which reveals that bevacizumab is more useful than retinal laser coagulation as it causes less astigmatism.

  • Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity. Atchaneeyasakul, L-O.; Trinavarat, A. // Journal of Perinatology;Jul2010, Vol. 30 Issue 7, p497 

    In recent times, laser treatment combined with intravitreal bevacizumab (Avastin) has been used rarely as early investigations to treat patients with aggressive posterior retinopathy of prematurity (ROP). We describe choroidal ruptures that were documented at 10 weeks after this combined...

  • Adjunctive effect of intravitreal bevacizumab prior to lens-sparing vitrectomy in aggressive posterior retinopathy of prematurity: a case report. Sun, Hae; Choi, Kyung; Lee, Sung // Japanese Journal of Ophthalmology;Sep2012, Vol. 56 Issue 5, p476 

    Background: Intravitreal injection of bevacizumab in retinopathy of prematurity has shown satisfactory results without any systemic complications. However, increased fibrosis and tissue contraction are reported as adverse effects in some cases. Case: A premature girl, born at 29 weeks + 4 days...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics